They also found that after the extra chromosome was removed, genes tied to nervous system development were more active and ...

Back in 1900 the life expectancy of people with Down Syndrome was 9 years. In 1984, it was 28 years, today it's leveled off ...

Editas Medicine ( EDIT 12.04%) is a promising clinical-stage company that has captured Wall Street's attention at the ...

Designing proteins with the help of AI can boost R&D massively. Proteins can be designed to destroy PFAS, to remove the ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.11, a high estimate of $68.00, ...

A schematic diagram of the development of next-generation RNA gene editing technology using induction evolution The Catholic ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

New CRISPR alternative can 'install' whole genes, paving the way to treatment for many genetic disorders Man gets sperm-making stem cell transplant in first-of-its-kind procedure ...